Co-Diagnostics (STU:C97) FCF Yield % : -59.90 (As of Jun. 25, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Co-Diagnostics FCF Yield %?

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Co-Diagnostics's Trailing 12-Month Free Cash Flow is €-24.26 Mil, and Market Cap is €40.92 Mil. Therefore, Co-Diagnostics's FCF Yield % for today is -59.90%.

The historical rank and industry rank for Co-Diagnostics's FCF Yield % or its related term are showing as below:

STU:C97' s FCF Yield % Range Over the Past 10 Years
Min: -83.75 Med: -3.38 Max: 25.76
Current: -59.9

During the past 9 years, the highest FCF Yield % of Co-Diagnostics was 25.76%. The lowest was -83.75%. And the median was -3.38%.

STU:C97's FCF Yield % is ranked worse than
88.7% of 867 companies
in the Medical Devices & Instruments industry
Industry Median: -2.9 vs STU:C97: -59.90

Co-Diagnostics's FCF Margin % for the quarter that ended in Mar. 2024 was -3,511.16%.

Co-Diagnostics FCF Yield % Historical Data

The historical data trend for Co-Diagnostics's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Co-Diagnostics FCF Yield % Chart

Co-Diagnostics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Yield %

Get a 7-Day Free Trial

-36.14

9.39

13.39

6.71

-51.48

Co-Diagnostics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
FCF Yield %	Get a 7-Day Free Trial															-55.00	-61.65	-82.04	-46.05	-104.20

Competitive Comparison of Co-Diagnostics's FCF Yield %

For the Medical Devices subindustry, Co-Diagnostics's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Co-Diagnostics's FCF Yield % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Co-Diagnostics's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Co-Diagnostics's FCF Yield % falls into.

Co-Diagnostics FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Co-Diagnostics's FCF Yield % for the fiscal year that ended in Dec. 2023 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-21.501	/	41.7629592
	=	-51.48%

Co-Diagnostics's annualized FCF Yield % for the quarter that ended in Mar. 2024 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-8.181	*	4	/	31.4035136
	=	-104.20%

Co-Diagnostics FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Co-Diagnostics FCF Yield % Related Terms

Thank you for viewing the detailed overview of Co-Diagnostics's FCF Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.

Co-Diagnostics (STU:C97) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Co-Diagnostics Inc (STU:C97) » Definitions » FCF Yield %

Comparable Companies

Traded in Other Exchanges

CODX:USA 0A50:UK

Address

2401 South Foothill Drive, Salt Lake City, UT, USA, 84109

Website

https://www.codiagnostics.com

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.

Co-Diagnostics (STU:C97) Headlines

No Headlines